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Background: Smoking cessation programs are critical to the safety and health of workers. Exhaled carbon
monoxide (CO) is an effective indicator of smoking in clinics and hospitals. Its application in the community
and workplace, however, remains limited. This study assessed whether exhaled CO concentration can be
used as an objective indicator of the amount of daily cigarette consumption among smokers in the workplace
in Taiwan.
Methods: A total of 150 workers from a chemical manufacturer in Taiwan were included; there were 27
nonsmokers and 123 current smokers. The number of cigarettes smoked daily by each subject was reported,
and exhaled CO concentration was measured in each subject using the Micro CO meter (Micro Medical Ltd,
Chatham, Kent, UK).
Results: Exhaled CO levels were associated with the number of cigarettes consumed daily, with a correlation
coefficient of 0.73 (p < 0.01) and an adjusted R-square (simple linear regression model) of 0.44. The mean
exhaled CO level of nonsmokers was 4.2 ppm (95% confidence interval, 3.3–5.1). A reading of > 6 ppm had
a sensitivity of 84% and specificity of 85% in detecting workplace smoking.
Conclusion: Exhaled CO level can be used as an objective, noninvasive indicator to determine the smoking
status of an individual in the workplace. [J Formos Med Assoc 2006;105(3):210–213]
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Despite the fact that smoking is associated, both
etiologically and prognostically, with numerous
diseases, the prevalence of smoking remains
high in Taiwan, with adult smoking prevalence
at 45.9% and 6.2% for males and females, re-
spectively.1 Consequently, the implementation of
effective smoking cessation programs is very im-
portant; such programs require a valid and con-
venient method of monitoring smoking status to
assess program effectiveness. In addition, demon-
stration of the immediate and potentially harmful
consequence of smoking by using a portable de-
vice might increase a smoker’s compliance with the
cessation program.2
*Correspondence to: Dr. Chang-Chuan Chan, Room 1447, Institute of Occupational Medicine and Industrial Hygiene,
College of Public Health, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei 100, Taiwan.
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Some methods for distinguishing smokers from
nonsmokers, such as the measurement of nico-
tine, cotinine, or thiocyanate levels in the plasma
or urine, are either invasive or time consuming.3
Exhaled carbon monoxide (CO) level is well cor-
related with blood carboxyhemoglobin level;4–6
it has also been reported to be highly correlated
with smoking status, and measuring exhaled CO
level using a portable and noninvasive CO moni-
tor has been widely adopted for assessing individ-
uals’ smoking status.2,3,7
The Tobacco Hazards Prevention Act was pro-
mulgated in Taiwan in 1997, and a series of smok-
ing cessation programs were implemented both
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calibrated with a mixture of 50 ppm CO in air.
Subjects were asked not to smoke for at least 1 hour
before CO measurement. Subjects were instructed
to exhale completely, inhale fully, hold their breath
for 15 seconds, and then to exhale rapidly into a
disposable mouthpiece, from which the reading of
CO level can be directly obtained. The measure-
ment was performed twice. There was no passive
smoking in the workplace, and the mean ambient
CO concentration during the study period was 0.4
ppm (as detected in the nearby monitor station).
Statistical analysis
All statistical analyses were conducted using
SAS version 8.2 (SAS Institute Inc, Cary, NC, USA).
Descriptive summary statistics, Spearman’s cor-
relation analyses, and simple linear regression
model were used to evaluate the relationship be-
tween exhaled CO level and the amount of daily
cigarette consumption. The CO concentration giv-
ing the optimum sensitivity and specificity was
selected as the cut-off point for differentiating
smokers from nonsmokers using a two-by-two
table.
Results
The age, weight, and height of subjects in the
smoking and nonsmoking groups are shown in
Table 1. All subjects were male. According to their
medical records, none of the subjects had any
significant respiratory or cardiovascular diseases.
The mean amount of daily cigarette consumption
(± standard deviation) among the current smok-
ers was 14.7 ± 7.5 cigarettes/day. Exhaled CO lev-
els were detectable in all subjects. Table 2 shows
officially and privately.8,9 Questions regarding dai-
ly cigarette consumption are often asked through-
out the course of such programs. However, many
smokers deny or under-report their real cigarette
consumption, making it impossible to obtain an
accurate assessment.
Smoking cessation programs are especially im-
portant in the workplace, particularly in chemical
manufacturing, due to the additional safety con-
cerns. Smoking behavior in the workplace is often
subjected to additional restrictions compared to
that in the community, usually for safety reasons.
Workers tend to smoke less during working hours
than during other activities. This might affect
the exhaled CO level measured in the workplace.
The objective of this study was to evaluate the
feasibility of using exhaled CO monitoring to as-
sess the smoking status among workers in a chem-
ical manufacturing plant, as part of a workplace
smoking cessation program.
Methods
In 2003, a smoking cessation program was con-
ducted in a chemical manufacturing plant employ-
ing 300 workers in Taiwan. A total of 150 workers
were recruited to participate in the program.
Among them, 27 were nonsmokers and the other
123 were current smokers. A nonsmoker was
defined as an individual who had not smoked for
at least 1 year before the study, and a smoker was
defined as an individual who had smoked regular-
ly in the past 1 year. Worksite smoking prohibi-
tion at the chemical manufacturing plant had
been a company policy enforced since 1997, and
workers were only allowed to smoke in designated
smoking areas outside of buildings. All subjects
were informed of the purpose of the study, and
they were reassured that the results would be kept
confidential to encourage accurate reporting of
smoking history. They were asked about their
medical and smoking histories. Exhaled CO level
was measured in parts per million (ppm) using a
Micro CO meter (Micro Medical Ltd, Chatham,
Kent, UK). Prior to the study, the CO meter was
Table 1. Age, body weight and height of subjects*
Smokers (n = 123) Nonsmokers (n = 27)
Age, yr 39.8 ± 6.0 43.7 ± 7.6
Weight, kg 071.7 ± 10.6 67.9 ± 8.2
Height, cm 167.9 ± 6.70 165.3 ± 5.40
*All subjects were male, and none had any significant respiratory or cardiovascular
diseases. Data presented as mean ± standard deviation.
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the mean exhaled CO levels of the subjects with
different smoking status. The mean exhaled CO
level of nonsmokers was 4.2 ppm (95% confi-
dence interval, 3.3–5.1). A CO reading > 6 ppm
suggested that the individual might be a smoker
with a sensitivity and specificity of 84% and 85%,
respectively. There was a significant positive cor-
relation between exhaled CO level and the self-
reported amount of daily cigarette consumption
(r = 0.73, p < 0.01, Spearman’s test). The regres-
sion coefficient in the simple regression model
was 0.70 (F value = 97.1, p < 0.01, adjusted R-
square = 0.44) (Figure).
Discussion
Although many factors might affect exhaled
CO level, the most likely cause of high levels of
CO exposure is smoking.2 The time period between
the last cigarette smoked and CO measurement
is an important consideration in individual smok-
ing status according to the exhaled CO level. This
might explain why the mean exhaled CO level of
those consuming 1–10 cigarettes a day was signi-
ficantly lower than the mean exhaled CO level
of those consuming > 10 cigarettes a day in this
study. In contrast, there was no significant differ-
ence in mean exhaled CO levels between individ-
uals consuming 11–20 cigarettes a day and those
consuming > 20 cigarettes a day (Table 2). Those
consuming more cigarettes tend to visit the smok-
ing areas and smoke during working hours, which
explains their higher exhaled CO levels measured
in the workplace. However, because of the limita-
tion of time, individuals who generally smoke >
20 cigarettes a day might not easily smoke more
than those who smoke 11–20 cigarettes a day dur-
ing working hours.
Jarvis et al studied 211 hospital outpatients
and reported that the optimal cut-off to differenti-
ate a smoker from a nonsmoker was 8 ppm, with
a sensitivity and specificity of 90% and 89%,
respectively.3 Wald et al studied 11,249 men aged
35–64 years attending a medical center for health
screening examination and also reported that a
cut-off of 1.5% COHb in the blood (which corre-
sponds to an exhaled CO level of approximate-
ly 8 ppm) differentiated a smoker from a non-
smoker with a sensitivity of 86% and specificity of
96.6%.5 In other studies using exhaled CO
monitors, a CO level of 10 ppm was used as the
cut-off.10,11 However, our results suggest that such
a high cut-off level might reduce the sensitivity
of CO monitoring, as a better diagnostic value
Figure. Correlation between exhaled carbon monoxide (CO) levels and the number
of cigarettes consumed daily in 123 current smokers. The dashed lines indicate the
95% confidence interval, and the dotted lines indicate the 95% prediction interval.
Table 2. Mean exhaled carbon monoxide (CO) level of subjects with different smoking status
Smoking status
Mean number of cigarettes Mean exhaled CO level,
consumed per day (SD) ppm (95% CI)
Nonsmoker (n = 27) 4.2 (3.3–5.1)0
Smoker (n = 123)
1–10 cigarettes/day (n = 49) 07.4 (2.5) 9.1 (7.9–10.3)
11–20 cigarettes/day (n = 65) 18.0 (2.8) 18.1 (16.5–19.6)
> 20 cigarettes/day (n = 9) 29.1 (5.0) 20.3 (12.4–28.3)
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was obtained at a CO cut-off of 6 ppm, in accord-
ance with the work of Middleton and Morice,
who also showed that a cut-off level of exhaled
CO of 6 ppm detected 94% of smokers and 96%
of nonsmokers in a respiratory outpatient clinic.2
Because smoking behavior in the workplace is dif-
ferent from that in the community, we did mis-
classify smokers as nonsmokers. Consequently,
the sensitivity of the best cut-off point to differen-
tiate smokers from nonsmokers in this study was
only 84%.
In conclusion, this study supports a good
correlation between exhaled CO level and daily
cigarette consumption in the workplace in Taiwan.
The exhaled CO monitor can be used to monitor
smoking status, and can be combined with a smok-
ing cessation program for health promotion. A
reading of > 6 ppm is a good cut-off point that
strongly indicates that an individual is a current
smoker.
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